Researchers at the University of Bonn in Germany have succeeded in finding a potentially low-cost source of a potent antiviral compound known to prevent replication of the HIV virus in vitro.

On 26 January, in London, Science|Business organised a roundtable of executives in the biotech industry to discuss the state of the market. The consensus: investor appetite for biotech companies is on the rise.

Europe preaches the knowledge society, but its aversion to risk and reluctance to change has got to go, warns Esko Aho, former prime minister of Finland.

There is much more work to do to convince public opinion that bioscience is a force for good, says UK BioIndustry Association chairman Simon Best.

Ireland's fastest-growing companies hired even more aggressively than other top job-creating European companies during 2001-2004, according to a survey conducted by Entrepreneurs for Growth, a membership-based organisation representing 2,000 European firms.

Dental implant company Neoss Ltd raised £5 million in its third funding round, enabling it to further develop the technology and expand its sales and marketing operations.